| Descriptor English: | Immunoproliferative Small Intestinal Disease | ||||||
| Descriptor Spanish: |
Enfermedad Inmunoproliferativa del Intestino Delgado
| ||||||
| Descriptor Portuguese: | Doença Imunoproliferativa do Intestino Delgado | ||||||
| Descriptor French: | Maladie immunoproliférative de l'intestin grêle | ||||||
| Entry term(s): |
Disease, alpha-Chain Diseases, alpha-Chain Heavy Chain Disease, IgA Type IPSID Lymphoma, Mediterranean Mediterranean Lymphoma alpha Chain Disease alpha-Chain Disease alpha-Chain Diseases |
||||||
| Tree number(s): |
C04.557.386.390 C06.301.371.411.512 C06.405.249.411.512 C06.405.469.491.505 C15.378.147.780.490.512 C15.604.515.435.512 C20.683.515.512 C20.683.780.490.512 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007161 | ||||||
| Scope note: | A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA. |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Previous Indexing: |
Heavy Chain Disease (1966-1986) Intestinal Neoplasms (1966-1986) Lymphoma (1966-1986) |
||||||
| Public MeSH Note: | 87 |
||||||
| History Note: | 87 |
||||||
| Entry Version: | IMMUNOPROLIFERATIVE SMALL INTESTINAL DIS |
||||||
| DeCS ID: | 19205 | ||||||
| Unique ID: | D007161 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1987/01/01 | ||||||
| Date of Entry: | 1986/06/24 | ||||||
| Revision Date: | 2018/06/29 |
-
-
DISEASES
Neoplasms [C04]Neoplasms
|
|
Immunoproliferative Small Intestinal Disease
- Preferred
| Concept UI |
M0011165 |
| Scope note | A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA. |
| Preferred term | Immunoproliferative Small Intestinal Disease |
| Entry term(s) |
Disease, alpha-Chain Diseases, alpha-Chain Heavy Chain Disease, IgA Type IPSID Lymphoma, Mediterranean Mediterranean Lymphoma alpha Chain Disease alpha-Chain Disease alpha-Chain Diseases |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
